Fig. 2From: The prognostic significance of the neutrophil-to-lymphocyte ratio and the platelet-to-lymphocyte ratio in giant cell tumor of the extremitiesRecurrence-free survival curve of patients with giant cell tumor of the extremities after surgery. The recurrence-free rates of patients at 1 year, 3 years, and 5 years after surgery were 94.27, 82.27, and 76.62%, respectivelyBack to article page